Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses.
暂无分享,去创建一个
K. Becker | D. Troyer | M. Tamura | Susumu Ishiguro | A. Kawabata | Yong Zhang | N. Ohta | M. Pyle | Garret T. Seiler
[1] Min-Wei Chen,et al. Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell–cell contact and internalization , 2012, Journal of cellular and molecular medicine.
[2] Lingyun Sun,et al. Banking Human Umbilical Cord-Derived Mesenchymal Stromal Cells for Clinical Use , 2012, Cell transplantation.
[3] K. Becker,et al. Wharton's Jelly Stem Cells as Agents for Cancer Therapy , 2011 .
[4] M. Kay,et al. Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells , 2011, Cell transplantation.
[5] F. Marini,et al. Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. , 2010, Lung cancer.
[6] T. Veenstra,et al. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo , 2010, BMC medicine.
[7] Shilpa Shankar,et al. Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially , 2010, PloS one.
[8] D. Stippel,et al. Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. , 2009, World journal of gastroenterology.
[9] M. Mattson,et al. Possible angiogenic roles for claudin-4 in ovarian cancer , 2009, Cancer biology & therapy.
[10] D. Troyer,et al. Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. , 2009, Cancer letters.
[11] M. Weiss,et al. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. , 2009, Cancer research.
[12] E. Jaffee,et al. Use of tumour-responsive T cells as cancer treatment , 2009, The Lancet.
[13] F. Farina,et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers , 2009, Histochemistry and Cell Biology.
[14] M. Weiss,et al. Immune Properties of Human Umbilical Cord Wharton's Jelly‐Derived Cells , 2008, Stem cells.
[15] H. Hsu,et al. Monocyte chemotactic protein-1 in the migration of differentiated leukaemic cells toward alveolar epithelial cells , 2008, European Respiratory Journal.
[16] P. Lowenstein,et al. Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials , 2008, PloS one.
[17] M. Weiss,et al. Concise Review: Wharton's Jelly‐Derived Cells Are a Primitive Stromal Cell Population , 2008, Stem cells.
[18] Shing-Hwa Liu,et al. Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 Diabetes , 2008, PloS one.
[19] M. Weiss,et al. Combination Treatment of Human Umbilical Cord Matrix Stem Cell-Based Interferon-Beta Gene Therapy and 5-Fluorouracil Significantly Reduces Growth of Metastatic Human Breast Cancer in SCID Mouse Lungs , 2008, Cancer investigation.
[20] M. Colombo,et al. Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy , 2007, Nature Reviews Cancer.
[21] M. Weiss,et al. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors , 2007, Cancer Gene Therapy.
[22] Stefano Papa,et al. NK Cells and Cancer1 , 2007, The Journal of Immunology.
[23] M. Beyer,et al. Regulatory T cells in cancer. , 2006, Blood.
[24] Christine E. Brown,et al. Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells1 , 2006, The Journal of Immunology.
[25] S. Kaneko,et al. Prolonged, NK Cell-Mediated Antitumor Effects of Suicide Gene Therapy Combined with Monocyte Chemoattractant Protein-1 against Hepatocellular Carcinoma , 2006, The Journal of Immunology.
[26] M. Weiss,et al. Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease , 2006, Stem cells.
[27] Karey Shumansky,et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). , 2005, Blood.
[28] D. Proia,et al. Stroma: Tumor Agonist or Antagonist , 2005, Cell cycle.
[29] H. Friess,et al. Loss of heterozygosity in the HLA class I region in human pancreatic cancer. , 2004, Tissue antigens.
[30] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[31] G. Page,et al. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture , 2004, Breast Cancer Research.
[32] H. Putter,et al. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis , 2004, Laboratory Investigation.
[33] K. Becker,et al. Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.
[34] W. Seeger,et al. Monocytes Are Potent Facilitators of Alveolar Neutrophil Emigration During Lung Inflammation: Role of the CCL2-CCR2 Axis1 , 2003, The Journal of Immunology.
[35] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[36] M. Weiss,et al. Matrix Cells from Wharton's Jelly Form Neurons and Glia , 2003, Stem cells.
[37] C. June,et al. Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.
[38] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[39] A. Enk,et al. Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.
[40] P. Schlag,et al. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. , 2001, Cancer research.
[41] M. Shekhar,et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.
[42] M. Barcellos-Hoff,et al. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.
[43] G. Millot,et al. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co‐culture , 1997, International journal of cancer.
[44] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[45] J. Foekens,et al. Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources , 1996, International journal of cancer.
[46] R. L. Baldwin,et al. Secreted ovarian stromal substance inhibits ovarian epithelial cell proliferation. , 1995, Gynecologic oncology.
[47] T. Springer,et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] S. Steinberg,et al. Localization of 111Indium‐labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response , 1994, Cancer.
[49] D. Sachs,et al. Immunogenicity of umbilical cord tissue derived cells. , 2008, Blood.
[50] C. Ostwald,et al. Prognostic role of CD8+ tumor infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability , 2004 .
[51] D. Kaufman,et al. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. , 2002, Cancer research.
[52] T. Kuroishi,et al. An ecological study on diet/nutrition and cancer in Japan , 1997, International journal of cancer.
[53] K. Matsushima,et al. Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.
[54] E. Leonard,et al. Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.
[55] E. Leonard,et al. Human monocyte chemoattractant protein-1 (MCP-1). , 1991, Advances in experimental medicine and biology.